ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Enregistré dans:
Auteurs principaux: | Robert W. Ariss, Rajesh Gupta |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/90ecf47a6c5646ad8073255d61c6e78c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
par: Aarti Thakkar, et autres
Publié: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
par: Anne Mirjam Kerola, et autres
Publié: (2021) -
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
par: Charles Amir German, et autres
Publié: (2020) -
Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
par: Jiang Li, et autres
Publié: (2021) -
Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
par: Ajay K. Gupta
Publié: (2018)